Close this search box.

Italy plans to import 400 kilos of medicinal cannabis to treat diseases


Read in Spanish

The Italian government has officially opened a request to import 400 kilos of cannabis with a high medicinal grade.

Given the lack of willingness of the government of Matteo Salvini to produce on locally, the European country opens the possibility to other countries of the European Union to produce medicines with high standards of purity by importing flowers.

The details of said request were published through the Ministry of Defense and its office Stabilimento Chimico Farmaceutico Militare (SCFM).

The application will be submitted between July 2-3.

High grade cannabis

According to information released by the government, the State would invest 1.52 million euros for 400 kilograms whose final price would be 3.8 euros for each gram.

The government demands that cannabis be high grade, that means that it meets the required requirements such as Good Manufacturing Practices (GMP) and Good Agricultural Practices and Collection of Medicinal Plants (GCAP) as established by international standards the World Health Organization (WHO).

In 2018, the Italian government imported a total of 100 kilograms from canadian company Aurora Cannabis. Previously, the company Bedrocan from the Netherlands has done it with 400 kilograms in 2017 and it is expected that 700 kilos will be imported this year.

On the other hand, the military pharmaceutical establishment has already contributed a total of 10-150 kilos in 2018.

The tender that the company Aurora Cannabis won in 2018 allowed the export of 320 kilograms of tall flowers in THC, 400 of tall flowers in THC / CBD and 40 kilos of tall flowers in CBD.

Italy is considered the second largest medicinal cannabis market in Europe. It is estimated that the market would rise this year by 40%.





Adolescent Cannabis Consumption Linked to Memory Decline

January 18, 2024

Smoking cannabis is not a good idea for pregnant woman

January 18, 2024

Study: Amitriptyline and CBD combination work in inflammatory pain reduction

January 18, 2024